92 related articles for article (PubMed ID: 32009256)
21. MicroRNA-195 suppresses colorectal cancer cells proliferation via targeting FGF2 and regulating Wnt/β-catenin pathway.
Zhang X; Xu J; Jiang T; Liu G; Wang D; Lu Y
Am J Cancer Res; 2016; 6(11):2631-2640. PubMed ID: 27904776
[TBL] [Abstract][Full Text] [Related]
22. Targeting Wnt signaling for improved glioma immunotherapy.
Gutova M; Hibbard JC; Ma E; Natri HM; Adhikarla V; Chimge NO; Qiu R; Nguyen C; Melendez E; Aguilar B; Starr R; Yin H; Rockne RC; Ono M; Banovich NE; Yuan YC; Brown CE; Kahn M
Front Immunol; 2024; 15():1342625. PubMed ID: 38449858
[TBL] [Abstract][Full Text] [Related]
23. miR‑149‑3p suppresses the proliferation and metastasis of glioma cells by targeting the CBX2/Wnt/β‑catenin pathway.
Wang Y; Song Y; Liu Z; Li J; Wang G; Pan H; Zheng Z
Exp Ther Med; 2023 Dec; 26(6):562. PubMed ID: 37954123
[TBL] [Abstract][Full Text] [Related]
24. Increased H3K4me3 methylation and decreased miR-7113-5p expression lead to enhanced Wnt/β-catenin signaling in immune cells from PTSD patients leading to inflammatory phenotype.
Bam M; Yang X; Busbee BP; Aiello AE; Uddin M; Ginsberg JP; Galea S; Nagarkatti PS; Nagarkatti M
Mol Med; 2020 Nov; 26(1):110. PubMed ID: 33189141
[TBL] [Abstract][Full Text] [Related]
25. miR-145-5p inhibits psoriasis progression by regulating the Wnt/β-catenin pathway.
Wang Y; Cao Y
Am J Transl Res; 2021; 13(9):10439-10448. PubMed ID: 34650713
[TBL] [Abstract][Full Text] [Related]
26. miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma.
Yuan S; Zhang P; Wen L; Jia S; Wu Y; Zhang Z; Guan L; Yu Z; Zhao L
Oncogene; 2021 Sep; 40(39):5799-5813. PubMed ID: 34345013
[TBL] [Abstract][Full Text] [Related]
27. Downregulated M6A modification and expression of circRNA_103239 promoted the progression of glioma by regulating the miR-182-5p/MTSS1 signalling pathway.
Zhang S; Zhang P; Wu A; Xu Z; Huang S; Liu X; Dong J
J Cancer; 2023; 14(18):3508-3520. PubMed ID: 38021156
[TBL] [Abstract][Full Text] [Related]
28. Enhanced expression of miR-204 attenuates LPS stimulated inflammatory injury through inhibiting the Wnt/β-catenin pathway via targeting CCND2.
Zheng Z; Wang X; Zheng Y; Wu H
Int Immunopharmacol; 2024 Jan; 126():111334. PubMed ID: 38061119
[TBL] [Abstract][Full Text] [Related]
29. TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt/β-catenin signaling pathway.
Yang H; Zhou H; Fu M; Xu H; Huang H; Zhong M; Zhang M; Hua W; Lv K; Zhu G
Int J Biol Macromol; 2024 Mar; 260(Pt 1):129332. PubMed ID: 38232867
[TBL] [Abstract][Full Text] [Related]
30. MPZL1 suppresses the cancer stem-like properties of lung cancer through β-catenin/TCF4 signaling.
Ge Q; Zhou C; Zang C; Li C; Hong H; Wang K; Chen L; Zhu H; Wang A
Funct Integr Genomics; 2023 Sep; 23(4):304. PubMed ID: 37726580
[TBL] [Abstract][Full Text] [Related]
31. Inhibitor of Wnt receptor 1 suppresses the effects of Wnt1, Wnt3a and β‑catenin on the proliferation and migration of C6 GSCs induced by low‑dose radiation.
Yan Y; Cheng YY; Li YR; Jiao XW; Liu YM; Cai HY; Ding YX
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099414
[TBL] [Abstract][Full Text] [Related]
32. miR-146a promotes growth of osteosarcoma cells by targeting ZNRF3/GSK-3β/β-catenin signaling pathway.
Zhou C; Jiang CQ; Zong Z; Lin JC; Lao LF
Oncotarget; 2017 Sep; 8(43):74276-74286. PubMed ID: 29088784
[TBL] [Abstract][Full Text] [Related]
33. Activation of Wnt Pathway Suppresses Growth of MUG-Chor1 Chordoma Cell Line.
Şişli HB; Hayal TB; Şenkal S; Bulut E; Kıratlı B; Asutay AB; Şahin F; Bayrak ÖF; Doğan A
Cell Biochem Biophys; 2023 Dec; 81(4):823-837. PubMed ID: 37751039
[TBL] [Abstract][Full Text] [Related]
34. AMBRA1 Negatively Regulates the Function of ALDH1B1, a Cancer Stem Cell Marker, by Controlling Its Ubiquitination.
Baek SH; Jang YK
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769507
[TBL] [Abstract][Full Text] [Related]
35. Impact of heterogeneous nuclear ribonucleoprotein A/B subtype overexpression on the expression of cancer stem cell markers CD133 and CD44 and cellular proliferation capacity.
Wang M; Wang X; Cui Y; Wen X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):101-108. PubMed ID: 38279469
[TBL] [Abstract][Full Text] [Related]
36. Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma.
Hao J; Han X; Huang H; Yu X; Fang J; Zhao J; Prayson RA; Bao S; Yu JS
Nat Commun; 2023 Apr; 14(1):2262. PubMed ID: 37080989
[TBL] [Abstract][Full Text] [Related]
37. The role and mechanism of miR-374 regulating the malignant transformation of mesenchymal stem cells.
Sun Z; Chen J; Zhang J; Ji R; Xu W; Zhang X; Qian H
Am J Transl Res; 2018; 10(10):3224-3232. PubMed ID: 30416663
[TBL] [Abstract][Full Text] [Related]
38. Targeting β-catenin using XAV939 nanoparticle promotes immunogenic cell death and suppresses conjunctival melanoma progression.
Antony F; Kang X; Pundkar C; Wang C; Mishra A; Chen P; Babu RJ; Suryawanshi A
Int J Pharm; 2023 Jun; 640():123043. PubMed ID: 37172631
[TBL] [Abstract][Full Text] [Related]
39. Significant Genes Associated with Mortality and Disease Progression in Grade II and III Glioma.
Choi BM; Cheong JH; Ryu JI; Won YD; Min KW; Han MH
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672212
[TBL] [Abstract][Full Text] [Related]
40. TRIP6 enhances stemness property of breast cancer cells through activation of Wnt/β-catenin.
Zhao X; Jiang C; Xu R; Liu Q; Liu G; Zhang Y
Cancer Cell Int; 2020; 20():51. PubMed ID: 32082081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
